Allergan recalled certain breast implants from the market after the FDA said there was an increase in cases of a rare type of cancer and deaths among women receiving the implants
Allergan PLC recalled certain textured breast implants from the market after U.S. health regulators said there was an increase in cases of a rare type of cancer and deaths among women receiving the implants.
The U.S. Food and Drug Administration said Wednesday it asked Allergan to recall the implants because their continued sale “would likely cause serious, adverse health consequences and potentially death” from a cancer known as breast-implant-associated anaplastic large cell lymphoma, which develops in the body’s immune...
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Allergan Just Issued A Global Recall Of Its Textured Breast ImplantsAllergan has complied with the request for recall, now calling on suppliers and doctors offices to halt the sale and implantation of its various models of textured implants.
Read more »
Allergan Issues Worldwide Recall of Textured Breast ImplantsThe recall was requested by the FDA due to the risk of a type of cancer.
Read more »
FDA asks Allergan to recall textured breast implants worldwideAllergan Plc said on Wednesday it was recalling its Biocell textured breast impl...
Read more »
FDA requests recall of Allergan textured breast implants linked to cancerJUST IN: In a major reversal, FDA now says they are asking breast implant maker Allergan to recall its textured implants after the agency found a higher risk of cancer linked to those devices.
Read more »
FDA Now Wants Textured Breast Implants to Be RecalledAlmost three months after the Food and Drug Administration chose not to enact a wholesale ban of textured breast implants—a type of implant linked to a rare cancer—the agency has asked the breast implant maker Allergan to recall its textured implants currently available in the United States. According to the FDA, Allergan is “moving forward with a worldwide recall.”
Read more »